Growth Metrics

Trinity Biotech (TRIB) Non-Current Deferred Tax Liability (2016 - 2025)

Trinity Biotech's Non-Current Deferred Tax Liability history spans 17 years, with the latest figure at $4.7 million for Q4 2025.

  • On a quarterly basis, Non-Current Deferred Tax Liability rose 2.32% to $4.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $4.7 million, a 2.32% increase, with the full-year FY2025 number at $4.7 million, up 2.32% from a year prior.
  • Non-Current Deferred Tax Liability hit $4.7 million in Q4 2025 for Trinity Biotech, up from $4.6 million in the prior quarter.
  • Over the last five years, Non-Current Deferred Tax Liability for TRIB hit a ceiling of $5.4 million in Q2 2022 and a floor of $195000.0 in Q4 2023.
  • Historically, Non-Current Deferred Tax Liability has averaged $4.0 million across 5 years, with a median of $4.6 million in 2024.
  • Biggest five-year swings in Non-Current Deferred Tax Liability: crashed 96.14% in 2023 and later soared 2238.97% in 2024.
  • Tracing TRIB's Non-Current Deferred Tax Liability over 5 years: stood at $4.9 million in 2021, then rose by 4.12% to $5.1 million in 2022, then crashed by 96.14% to $195000.0 in 2023, then soared by 2238.97% to $4.6 million in 2024, then grew by 2.32% to $4.7 million in 2025.
  • Business Quant data shows Non-Current Deferred Tax Liability for TRIB at $4.7 million in Q4 2025, $4.6 million in Q2 2025, and $4.6 million in Q4 2024.